标题
Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes
作者
关键词
-
出版物
International Journal of Environmental Research and Public Health
Volume 19, Issue 13, Pages 8113
出版商
MDPI AG
发表日期
2022-07-04
DOI
10.3390/ijerph19138113
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
- (2022) Shuai Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Half of germline pathogenic and likely pathogenic variants found on panel tests do not fulfil NHS testing criteria
- (2022) Tala Andoni et al. Scientific Reports
- Non-Epithelial Ovarian Cancers: How Much Do We Really Know?
- (2022) Alison Cheung et al. International Journal of Environmental Research and Public Health
- Germline mutations in apoptosis pathway genes in ovarian cancer; the functional role of a TP53I3 (PIG3) variant in ROS production and DNA repair
- (2021) Sophia R. Chaudhry et al. Cell Death Discovery
- Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the Clinic
- (2021) Aruni Ghose et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer
- (2021) Christine Bekos et al. Journal of Personalized Medicine
- Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics
- (2021) Brittany L. Bychkovsky et al. CANCER
- The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment eras: 27 years data from the SEER registry
- (2021) Nicholas Pavlidis et al. Cancer Epidemiology
- A decade of RAD51C and RAD51D germline variants in cancer
- (2021) Jacopo Boni et al. HUMAN MUTATION
- BRCA Mutations in Prostate Cancer: Assessment, Implications and Treatment Considerations
- (2021) Sidrah Shah et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?
- (2020) Davide Angeli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline
- (2020) Panagiotis A. Konstantinopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial
- (2020) Richard T. Penson et al. JOURNAL OF CLINICAL ONCOLOGY
- Biophysicochemical motifs in T cell receptor sequences as a potential biomarker for high-grade serous ovarian carcinoma
- (2020) Jared Ostmeyer et al. PLoS One
- Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
- (2020) Stergios Boussios et al. Drugs in research & development
- BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases
- (2020) Malwina Suszynska et al. Journal of Ovarian Research
- Spectrum of Germline BRCA1 and BRCA2 Variants Identified in 2351 Ovarian and Breast Cancer Patients Referring to a Reference Cancer Hospital of Rome
- (2020) Concetta Santonocito et al. Cancers
- Wise Management of Ovarian Cancer: On the Cutting Edge
- (2020) Stergios Boussios et al. Journal of Personalized Medicine
- Ovarian Cancer Risk Variants Are Enriched in Histotype-Specific Enhancers and Disrupt Transcription Factor Binding Sites
- (2020) Michelle R. Jones et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation
- (2020) Win Topatana et al. Journal of Hematology & Oncology
- Prevalence of pathogenic variants in actionable genes in advanced ovarian cancer: a next-generation sequencing analysis of a nationwide registry study
- (2020) Sokbom Kang et al. EUROPEAN JOURNAL OF CANCER
- Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?
- (2020) Stergios Boussios et al. Annals of Translational Medicine
- Current practices on genetic testing in ovarian cancer
- (2020) Florentia Fostira et al. Annals of Translational Medicine
- Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?
- (2020) Michele Moschetta et al. Annals of Translational Medicine
- Ovarian cancer risk assessment in the era of next-generation sequencing
- (2020) Renata Colombo Bonadio et al. Annals of Translational Medicine
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- Epithelial ovarian cancer risk: A review of the current genetic landscape
- (2019) Nicola Flaum et al. CLINICAL GENETICS
- Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm
- (2019) Maria Luisa Gasparri et al. Medicina-Lithuania
- PARP Inhibitors in Ovarian Cancer: The Route to “Ithaca”
- (2019) Boussios et al. Diagnostics
- Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review
- (2019) Stergios Boussios et al. Diagnostics
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer
- (2019) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach
- (2019) Stergios Boussios et al. INVESTIGATIONAL NEW DRUGS
- Germline and somatic mutations of homologous recombination-associated genes in Japanese ovarian cancer patients
- (2019) Kentaro Sugino et al. Scientific Reports
- Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy
- (2019) Caterina Fumagalli et al. Cancers
- Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics
- (2018) Jaime Prat et al. HUMAN PATHOLOGY
- Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2
- (2018) Kyung Jin Eoh et al. Cancer Research and Treatment
- National Distribution of Cancer Genetic Testing in the United States
- (2018) Kimberly K. Childers et al. JAMA Oncology
- A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives
- (2018) Stergios Boussios et al. Journal of Advanced Research
- Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing
- (2018) Jacqueline Mersch et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap
- (2018) Jeanna M McCuaig et al. JOURNAL OF MEDICAL GENETICS
- Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management
- (2018) RR Bonadio et al. Clinics
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian carcinosarcoma: Current developments and future perspectives
- (2018) Stergios Boussios et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction
- (2017) Michelle R. Jones et al. GYNECOLOGIC ONCOLOGY
- Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls
- (2017) Jenna Lilyquist et al. GYNECOLOGIC ONCOLOGY
- Genetics Consultation Rates Following a Diagnosis of High-Grade Serous Ovarian Carcinoma in the Canadian Province of Ontario
- (2017) Jacob McGee et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification
- (2017) Rick Kamps et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B. Kuchenbaecker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High-risk epithelial ovarian cancer patients for hereditary ovarian cancer
- (2017) Seksit Chirasophon et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting
- (2017) Brian A. Dougherty et al. Oncotarget
- Epidemiology of ovarian cancer: a review
- (2017) Reid Brett M. et al. Cancer Biology & Medicine
- Non-epithelial Ovarian Cancer: Elucidating Uncommon Gynaecological Malignancies
- (2016) STERGIOS BOUSSIOS et al. ANTICANCER RESEARCH
- Frequency of germline PALB2 mutations among women with epithelial ovarian cancer
- (2016) Joanne Kotsopoulos et al. Familial Cancer
- Genetic characterization of early onset ovarian carcinoma
- (2016) Sarah S. Bernards et al. GYNECOLOGIC ONCOLOGY
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer
- (2016) Erin F. Cobain et al. SEMINARS IN ONCOLOGY
- Ovarian cancer
- (2016) Ursula A. Matulonis et al. Nature Reviews Disease Primers
- Inherited Mutations in Women With Ovarian Carcinoma
- (2016) Barbara M. Norquist et al. JAMA Oncology
- Tumor infiltrating lymphocytes in ovarian cancer
- (2015) Phillip P Santoiemma et al. CANCER BIOLOGY & THERAPY
- Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening
- (2015) Melissa K. Frey et al. GYNECOLOGIC ONCOLOGY
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- Targeting the DNA Damage Response in Cancer
- (2015) Mark J. O’Connor MOLECULAR CELL
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population
- (2014) H. Song et al. HUMAN MOLECULAR GENETICS
- Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
- (2014) Amy P.M. Finch et al. JOURNAL OF CLINICAL ONCOLOGY
- The Evolution of Cancer Risk Assessment in the Era of Next Generation Sequencing
- (2014) Heather Fecteau et al. Journal of Genetic Counseling
- PARP inhibition and synthetic lethality in ovarian cancer
- (2014) Ramez N Eskander et al. Expert Review of Clinical Pharmacology
- The admixture maximum likelihood test to test for association between rare variants and disease phenotypes
- (2013) Jonathan P Tyrer et al. BMC BIOINFORMATICS
- High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer
- (2013) Ryan O Emerson et al. JOURNAL OF PATHOLOGY
- Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer
- (2012) T Pal et al. BRITISH JOURNAL OF CANCER
- Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families
- (2012) D J Osher et al. BRITISH JOURNAL OF CANCER
- Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
- (2012) Kelly L. Bolton JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
- (2012) Kathryn Alsop et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytotoxic T-lymphocyte Immunotherapy for Ovarian Cancer
- (2012) Stephen E. Wright et al. JOURNAL OF IMMUNOTHERAPY
- ColoSeq Provides Comprehensive Lynch and Polyposis Syndrome Mutational Analysis Using Massively Parallel Sequencing
- (2012) Colin C. Pritchard et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
- (2011) P. M. L. H. Vencken et al. ANNALS OF ONCOLOGY
- Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer
- (2011) Shiyu Zhang et al. GYNECOLOGIC ONCOLOGY
- Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
- (2011) Wei-Ting Hwang et al. GYNECOLOGIC ONCOLOGY
- Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
- (2011) Da Yang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Germline mutations in RAD51D confer susceptibility to ovarian cancer
- (2011) Chey Loveday et al. NATURE GENETICS
- RAD51C Germline Mutations in Breast and Ovarian Cancer Cases from High-Risk Families
- (2011) Jessica Clague et al. PLoS One
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
- (2011) T. Walsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Are Surveillance Procedures of Clinical Benefit for Patients Treated for Ovarian Cancer?
- (2010) Angiolo Gadducci et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The DNA Damage Response: Making It Safe to Play with Knives
- (2010) Alberto Ciccia et al. MOLECULAR CELL
- Translating cancer research into targeted therapeutics
- (2010) J. S. de Bono et al. NATURE
- Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
- (2010) Alfons Meindl et al. NATURE GENETICS
- Ovarian carcinoma pathology and genetics: recent advances
- (2009) C. Blake Gilks et al. HUMAN PATHOLOGY
- Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy
- (2009) Tomasz Byrski et al. JOURNAL OF CLINICAL ONCOLOGY
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment for Recurrent Ovarian Cancer—At First Relapse
- (2009) Kimio Ushijima Journal of Oncology
- A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer
- (2008) Tuya Pal et al. CANCER
- Homologous recombination in DNA repair and DNA damage tolerance
- (2008) Xuan Li et al. CELL RESEARCH
- Uptake of clinical genetic testing for ovarian cancer in Ontario: A population-based study
- (2008) Kelly A. Metcalfe et al. GYNECOLOGIC ONCOLOGY
- A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment of Cancers Deficient in DNA Double-Strand Break Repair
- (2008) Alan Ashworth JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now